Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$106.37 - $130.68 $23,826 - $29,272
-224 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$102.91 - $122.75 $23,463 - $27,987
-228 Reduced 50.44%
224 $25,000
Q1 2021

Apr 20, 2021

BUY
$78.68 - $90.67 $5,428 - $6,256
69 Added 18.02%
452 $38,000
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $3,154 - $4,014
44 Added 12.98%
383 $35,000
Q2 2020

Jul 27, 2020

BUY
$57.54 - $76.95 $14,787 - $19,776
257 Added 313.41%
339 $23,000
Q1 2020

Apr 22, 2020

SELL
$52.41 - $81.0 $1,991 - $3,078
-38 Reduced 31.67%
82 $15,000
Q4 2019

Feb 03, 2020

BUY
$71.7 - $82.09 $7,815 - $8,947
109 Added 990.91%
120 $28,000
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $8,924 - $10,937
-145 Reduced 92.95%
11 $2,000
Q2 2019

Jul 12, 2019

BUY
$55.74 - $64.41 $8,695 - $10,047
156 New
156 $29,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.